Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
NCT05115045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122
Last updated 2023-04-03
Summary
Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.
Conditions
- COVID-19 Pneumonia
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
- DIAGNOSTIC_TEST
-
plasmatic SARS-CoV-2 RNA quantification
plasmatic SARS-CoV-2 RNA was quantified by droplet digital PCR
Sponsors & Collaborators
-
Hopital of Melun
lead OTHER
Principal Investigators
-
SEBASTIEN JOCHMANS · GHSIF MELUN
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-09
- Primary Completion
- 2021-12-31
- Completion
- 2022-03-01
Countries
- France
Study Locations
More Related Trials
-
The Prognostic Factors of COVID-19 ARDS Patients and Their Long-term Follow-up of Pulmonary Function Test
NCT05490914 ·Status: UNKNOWN
-
Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit
NCT04805645 ·Status: TERMINATED
-
Pulmonary Inflammation in COVID-19 ARDS
NCT04935450 ·Status: UNKNOWN
-
Recovery of Patients From COVID-19 After Critical Illness
NCT04401254 ·Status: COMPLETED
-
Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU
NCT04385004 ·Status: UNKNOWN
-
Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure
NCT04733105 ·Status: COMPLETED
-
Clinical Features of Severe Patients With COVID-19
NCT04450017 ·Status: COMPLETED
-
Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes
NCT05451342 ·Status: UNKNOWN
-
Survival Rates and Longterm Outcomes After COVID-19
NCT04601090 ·Status: COMPLETED
-
COVID-19 Patients Admitted to the ICU
NCT04816786 ·Status: UNKNOWN
-
Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19
NCT04586114 ·Status: UNKNOWN
-
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
NCT05330845 ·Status: TERMINATED ·Phase: NA
-
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.
NCT05624684 ·Status: COMPLETED
-
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
NCT01068990 ·Status: RECRUITING
-
The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients
NCT04817397 ·Status: COMPLETED
-
Acute and Chronic Pulmonary and Renal Complications Following Contracting Severe Respiratory Distress Syndrome Coronavirus-19
NCT04827017 ·Status: UNKNOWN
-
Outcomes and Prognostic Factors in COVID-19
NCT04321265 ·Status: UNKNOWN
-
Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19
NCT04388670 ·Status: UNKNOWN
-
Characteristics and Outcome of Patients With COVID-19 in ICUs in South Tyrol
NCT05077319 ·Status: COMPLETED
-
Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients
NCT05028244 ·Status: COMPLETED ·Phase: NA
-
Clinical Features of COVID-19 Patients
NCT04815304 ·Status: COMPLETED
-
Lung Ultrasound in COVID-19 Patients
NCT04487769 ·Status: COMPLETED
-
Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System
NCT04008225 ·Status: COMPLETED
-
Infection Surveillance in Intensive Care Patients
NCT00197847 ·Status: UNKNOWN
-
IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients
NCT07345169 ·Status: RECRUITING